Vertex Ventures Israel and Grove Ventures Capital Ltd have co-led a $5-million seed round in Nucleai Ltd, a Tel Aviv-based startup that uses artificial intelligence and machine learning algorithms to detect cancer and other diseases.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
